Age |
Never reported |
37 |
33.35 |
6.26 |
Reported ever, no current IPV |
37 |
34.62 |
6.55 |
Reported current IPV |
52 |
33.90 |
6.84 |
Total |
126 |
33.95 |
6.56 |
Race |
Never reported |
37 |
0.57 |
0.50 |
Reported ever, no current IPV |
37 |
0.49 |
0.51 |
Reported current IPV |
52 |
0.33 |
0.47 |
Total |
126 |
0.44 |
0.50 |
Treatment Group |
Never reported |
37 |
1.43 |
0.50 |
Reported ever, no current IPV |
37 |
1.46 |
0.51 |
Reported current IPV |
52 |
1.25 |
0.44 |
Total |
126 |
1.37 |
0.48 |
Treatment Attendance |
Never reported |
37 |
0.70 |
0.46 |
Reported ever, no current IPV |
37 |
0.76 |
0.43 |
Reported current IPV |
52 |
0.79 |
0.41 |
Total |
126 |
0.75 |
0.43 |
Percent days drug use |
Never reported |
37 |
63.09 |
33.32 |
Reported ever, no current IPV |
37 |
66.51 |
34.74 |
Reported current IPV |
52 |
73.38 |
27.49 |
Total |
126 |
68.34 |
31.55 |
DSI |
Never reported |
37 |
90.27 |
16.96 |
Reported ever, no current IPV |
37 |
74.54 |
15.58 |
Reported current IPV |
52 |
77.25 |
18.73 |
Total |
126 |
80.28 |
18.41 |
SE- General |
Never reported |
37 |
60.71 |
13.48 |
Reported ever, no current IPV |
37 |
56.59 |
12.73 |
Reported current IPV |
52 |
58.00 |
13.09 |
Total |
126 |
58.39 |
13.10 |